News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Ai2 and Google Cloud join Cancer AI Alliance with a total of $20M in commitments
The Allen Institute for AI (Ai2) is joining the Cancer AI Alliance, a national initiative led by Fred Hutch Cancer Center to accelerate cancer research

WSU researchers develop machine learning model to predict virus reservoirs
Researchers at Washington State University have developed a machine learning model that predicts which animal species are likely to host and transmit viruses, pinpointing potential

HSSA doles out over $4M for bioscience economic development
The Health Sciences & Services Authority (HSSA) of Spokane County awarded over $4.4 million in grants this winter to support bioscience innovation and expand healthcare

NIH Cuts Threaten to Cede U.S. Life Science Dominance to China
NIH funding is critical to maintaining American competitiveness and economic success. The Trump Administration’s proposed cuts to NIH’s indirect cost reimbursement threaten to undermine American

Cardiac Dimensions secures $53M bringing a new dimension to heart failure treatment
Cardiac Dimensions, a leader in minimally invasive heart failure treatments, raised $53 million in Series E funding to advance its Carillon Mitral Contour System for

GeekWire Awards: Health Innovation of the Year field is dominated by finalists battling cancer
LSW members Archon Biosciences, Fred Hutch Cancer Center, Talus Bioscience and Umoja Biopharma were named as finalists for GeekWire’s Health Innovation of the Year Award.

Shingles vaccine maker Curevo lands $110M, adds biotech vets to board
Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B round. Curevo’s efforts target shingles, a painful condition

Omeros Corporation Receives Commitment of Over $4 Million from NIDA for Further Development of the Company’s OMS527 Program to Treat Cocaine Use Disorder
Omeros received $4.02 million in funding from the National Institute on Drug Abuse (NIDA) for clinical development of its OMS527 program to treat cocaine use

AGC Biologics Honored for Excellence in Development and Manufacturing
AGC Biologics received two awards from the annual CDMO Leadership Awards, sponsored by Outsourced Pharma and Life Science Connect. “We are honored that our customers

Science Firsthand: Predicting new possibilities in drug discovery
Predictive technologies are transforming R&D, accelerating the development of high-quality medicines, and bringing life-changing treatments to patients faster than ever before. In the latest episode

In buying cell therapy partner 2seventy bio for $286M, BMS takes full control of Abecma
Bristol Myers Squibb (BMS) has agreed to buy out 2seventy bio for a total equity value of about $286 million. The two companies had previously

Bothell medical tech company eyes local expansion after $28 million raise
After raising $28.3 million, Bothell-based VerAvanti is expanding its footprint in the Seattle region. Founded in 2013, VerAvanti specializes in imaging solutions and is developing
